More results...

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Sweet furore: Aspartame as a possible cause of cancer, a WHO agency declares

The FDA and the powerful beverage industry protest the new findings, and a second WHO group stands by its standard that the sweetener is generally safe.

A WHO agency declared on 13 July that aspartame, the artificial sweetener widely used in diet drinks and low-sugar foods, could possibly cause cancer.

A second WHO committee, though, held steady on its assessment of a safe level of aspartame consumption. By some calculations using the panel’s standard, a person weighing 75kg could avoid a risk of cancer but still drink about a dozen cans of diet soda a day.

Aspartame has been a contentious ingredient for decades, but the declaration by a WHO agency, International Agency for Research on Cancer (IARC), of a cancer risk reflects the first time the WHO has weighed in publicly on the effects of the nearly ubiquitous artificial sweetener.

IARC said it based its conclusion that aspartame was a possible carcinogen on limited evidence from three observational studies of humans that the agency said linked consumption of artificially sweetened beverages to an increase in cases of liver cancer — at levels far below a dozen cans a day.

It cautioned that the results could potentially be skewed toward the profile of people who drink higher amounts of diet drinks and called for further study.

Still, people who consume high amounts of aspartame should consider switching to water or other unsweetened drinks, said Dr Francesco Branca, director of the WHO Department of Nutrition and Food Safety.

“Our results do not indicate that occasional consumption should pose a risk to most.” Dr Francesco Branca, director of the WHO Department of Nutrition and Food Safety

Concerns about rising global rates of obesity and diabetes as well as changing consumer preferences have resulted in an explosion of no- and low-sugar food and beverages. Aspartame, one of six sweeteners approved by US regulators, is found in thousands of products, from packets of Equal to sugar-free gum, diet sodas, teas, energy drinks and even yogurts. It is also used to sweeten various pharmaceutical products.

FDA protests

The US FDA, which approved aspartame decades ago, issued an unusual criticism of the global agency’s findings and reiterated its long-standing position that the sweetener is safe.

In a statement, the FDA said it “disagrees with IARC’s conclusion that these studies support classifying aspartame as a possible carcinogen to humans.”

The FDA also said that “aspartame being labelled by the WHO as ‘possibly carcinogenic to humans’ does not mean that aspartame is actually linked to cancer.”

But its salvo against the WHO was sure to ignite further debate in Europe — where the sweetener is still deemed safe — and renew review in the US. And the duelling global agencies’ pronouncements are likely to fuel confusion among consumers.

The WHO has occasionally been out of step with other authorities on potential cancer risks, like glyphosate, and later led the way toward establishing that it was dangerous to human health. The international body’s designation of a cancer link to that ingredient in Roundup, a weed killer, became the stepping stone for lawsuits against the makers of the herbicide.

Beverage industry protests

Around the world, the powerful beverage industry has fought long and hard against any regulatory or scientific finding that tied artificial sweetener use to risks of cancer or other health problems.

Aspartame is only the latest battleground for multinational companies to push back against new studies or potential links to health risks.

“Aspartame is safe,” Kevin Keane, interim president of the American Beverage Association, said in a statement. He cited the duelling WHO announcements, singling out the second panel, the Joint Expert Committee on Food Additives, that performed a concurrent review and left its recommended daily intake amount unchanged. It also deemed the evidence for cancer in humans “not convincing,” a WHO summary shows.

“After a rigorous review, the World Health Organization finds aspartame is safe and ‘no sufficient reason to change the previously established acceptable daily intake. This strong conclusion reinforces the position of the FDA and food safety agencies from more than 90 countries.” Kevin Keane, interim president of the American Beverage Association

Coca-Cola referred questions to the American Beverage Association and PepsiCo did not respond to requests for comment.

The controversial studies

The safety of sugar replacements, including the decades-old science dispute over the use of saccharin in the diet drink TaB, has been heavily scrutinized. Once linked to bladder cancer in rats, Congress mandated further study of saccharin. Since then, according to the FDA, 30 studies showed the rodent results did not apply to humans; US officials removed saccharin from a list of potential carcinogens. More recently, other sweeteners have come under scrutiny for their ties to possible health risks.

At the centre of the dispute over aspartame are rodent studies from 2005-2010 by Italy-based researchers that showed a link to cancer. The FDA has dismissed the long-debated studies as “compromised.”

Dr William Dahut, chief scientific officer of the American Cancer Society, which led one of the key studies the WHO relied on, said the findings should be considered alongside the WHO’s report earlier this year that indicated artificial sweeteners offered no help in achieving weight loss or protection from other chronic conditions.

He said there was little evidence now to suggest a daily Diet Coke would elevate the risk of cancer, adding that “more research is needed.” Overall, he said, the science was more definitive on reducing cancer risk by avoiding tobacco, alcohol, processed meat and excess body weight.

The IARC said it could not rule out the possibility that the studies linking aspartame to liver cancer were a result of chance or other factors associated with drinking diet soda.

The WHO’s cancer agency has four categories: carcinogenic, probably carcinogenic, possibly carcinogenic and no classification. Those levels reflect the strength of the science rather than how likely the substance is to cause cancer.

The other WHO group on food additives recommended that daily consumption should be below 40 mg of aspartame per kilogram of a person’s weight — slightly lower than the suggested US level of 50 mg.

The FDA said it estimated that a person weighing 59 kg would need to consume 75 packets of aspartame sweetener to reach the threshold of exposure to a potential risk.

For its review of aspartame, the IARC convened 25 cancer experts from 12 nations in Lyon, France, to conduct the review of existing studies. It concluded that there was limited evidence for cancer in humans based on three studies linking artificially sweetened drinks to increases in hepatocellular carcinoma, the most common type of liver cancer.

One study in 2016 was led by WHO officials, who looked at nearly 500,000 people in Europe who were followed for about 11 years. The study tracked participants’ juice and soft drink intake and the relationship to liver and bile duct cancers. It examined those who drank artificially sweetened soft drinks and found that each additional serving of diet soft drink a week was associated with a 6 percent increased risk of liver cancer.

A US study published last year by researchers from Harvard, Boston University and the National Cancer Institute examined sweetened beverage consumption reported by people on questionnaires and cancer case registries. Researchers found an elevated risk of liver cancer in people with diabetes who said they consumed two or more artificially sweetened sodas a day. That study found no increase in liver cancer among diet soda drinkers who did not have diabetes.

A third study, led by the American Cancer Society, examined the use of beverages sweetened by sugar and artificial sweeteners and cancer death data. It found a 44 percent increase in liver cancer among men who never smoked and drank two or more artificially sweetened drinks a day. Even adjusting for high body mass — in itself a cancer risk factor — the men had a 22 percent increase in risk, data in a supplement to the study shows.

The American Beverage Association, which represents Coca-Cola and PepsiCo, has been vocal in saying that the WHO’s food additive panel — not the cancer experts — should be the lead authority evaluating aspartame.

In recent weeks, the beverage industry trade group has financed a new coalition led by Alex Azar, an appointee of former President Donald J. Trump, and Donna Shalala, an appointee of former President Bill Clinton. Both Azar and Shalala were former secretaries of the Department of Health and Human Services. In an opinion article in Newsweek earlier this month, the two embraced the FDA’s position on the safety of aspartame, and called the agency “the world’s gold standard for independent regulatory bodies.”

The trade group had previously contested another review of aspartame’s potential links to cancer in California. In 2016, a state committee discussed reviewing aspartame, but it went no further.

California officials said this week that the state could review the latest WHO decision.

Besides aspartame, the WHO’s cancer agency has deemed other possible carcinogens to range from the seemingly benign, like Ginkgo biloba extract and aloe vera leaf extract, to the more concerning, like gasoline exhaust and perfluorooctanoic acid, the most common of the industrial chemicals known as per- and polyfluoroalkyl substances, or PFAS, that has recently been subject to billion-dollar settlements over drinking water contamination.

In deeming aspartame a possible carcinogen, the IARC also dipped into one of the central controversies of aspartame research. It concluded that there was some evidence for cancer in lab animals based on studies performed by the Ramazzini Institute in Italy, citing the group’s finding of increased tumors in aspartame studies from the mid-2000s. Based on concerns over the group’s methods and interpretations, though, the findings were deemed limited.

For its part, the Ramazzini Institute said in 2021 that its work on aspartame was validated and that its earlier findings were “savagely attacked by the chemical manufacturing and processed food industries and by their allies in regulatory agencies.”

Source: New York Times

Related reading:

No Comments

Sorry, the comment form is closed at this time.